Chemicals · Founded 1991 · www.crestchemlimited.in · BSE 526269 · · ISIN INE293N01016
No Notes Added Yet
Business
Crestchem Ltd. is an Indian company primarily engaged in the chemicals sector. Based on its industry classification, it is likely involved in the manufacturing and/or trading of various chemical products, which could include specialty chemicals, bulk chemicals, intermediates, or performance chemicals. The company's core business model involves producing and supplying these chemicals to a diverse range of industrial customers across different end-user sectors such as pharmaceuticals, agrochemicals, textiles, paints, and polymers. Its revenue is generated through the sale of these chemical products.
Revenue Mix
Specific detailed segment-wise revenue breakdown for Crestchem Ltd. is not readily available in public domain information typical for smaller/mid-sized companies. It likely operates largely within a single broad chemicals segment, or if it has multiple product lines, their contributions are not individually disclosed. Generally, companies in this sector might differentiate by product type (e.g., organic vs. inorganic, specialty vs. commodity) or by end-user application.
Industry
The Indian chemicals industry is diverse, comprising bulk chemicals, specialty chemicals, agrochemicals, pharmaceuticals, and petrochemicals. It is a highly competitive sector with a mix of large integrated players, mid-sized focused companies, and numerous small-scale manufacturers. The industry benefits from a large domestic market and growing export opportunities. Crestchem Ltd. likely operates as a smaller to mid-sized player within this landscape, potentially focusing on specific niches, product chemistries, or regional markets to differentiate itself among both domestic and international competitors. Its positioning would depend on its product portfolio's specialization and cost competitiveness.
MOAT
For a company like Crestchem Ltd., a significant, durable competitive advantage (moat) might be limited or derived from specific operational factors rather than broad brand recognition or network effects typical of consumer businesses. Potential sources of advantage could include:
Process Efficiency/Cost Leadership: Ability to manufacture chemicals at a lower cost due to optimized processes, captive raw material sourcing, or efficient scale.
Product Specialization/Niche Expertise: Focus on specific, high-demand, or complex specialty chemicals where entry barriers are higher due to R&D or technical know-how.
Customer Relationships: Long-standing relationships and supply chain integration with key industrial clients.
Regulatory Compliance: Adherence to stringent quality and environmental standards can act as a barrier to entry for new players.
However, the overall chemicals industry is capital-intensive and often cyclical, making sustainable moats challenging unless a company holds unique intellectual property or a dominant market share in a critical intermediate.
Growth Drivers
Key factors that can drive Crestchem Ltd.'s growth over the next 3-5 years include:
Growth in End-User Industries: Expanding demand from sectors like pharmaceuticals, agrochemicals, automotive, construction, and consumer goods in India and globally.
"China Plus One" Strategy: Global diversification of supply chains away from China could lead to increased export opportunities for Indian chemical manufacturers.
Import Substitution: Government initiatives and industry trends encouraging domestic manufacturing to reduce reliance on imports.
Capacity Expansion & New Product Development: Investment in enhancing manufacturing capacity, developing new chemistries, or backward/forward integration.
Government Support: Policies like Production Linked Incentive (PLI) schemes for certain chemical categories or focus on ease of doing business can be beneficial.
Risks
Crestchem Ltd. faces several risks inherent to the chemicals sector:
Raw Material Price Volatility: Fluctuations in the prices of key feedstocks (often crude oil derivatives or other commodity chemicals) can impact profitability, especially if price increases cannot be fully passed on to customers.
Intense Competition: Competition from domestic and international players can lead to pricing pressures and margin erosion.
Environmental & Regulatory Risks: Stringent environmental norms and evolving regulations regarding pollution control, waste disposal, and chemical safety can increase operational costs and compliance burdens.
Currency Fluctuations: For companies involved in exports or relying on imported raw materials, adverse movements in foreign exchange rates can impact profitability.
Economic Downturn: A slowdown in the global or domestic economy can reduce demand from key end-user industries.
Supply Chain Disruptions: Geopolitical events, natural disasters, or logistical challenges can disrupt raw material supply or product delivery.
Management & Ownership
Crestchem Ltd. is likely a promoter-driven company, which is common for many Indian businesses, especially in traditional industrial sectors like chemicals. The promoters typically hold a significant ownership stake and are actively involved in the company's strategic direction and day-to-day operations. Management quality would depend on their experience in the chemical industry, strategic vision, operational efficiency, and commitment to governance. Ownership structure would typically involve a substantial promoter holding, with the remaining shares held by public shareholders and potentially some institutional investors.
Outlook
The outlook for Crestchem Ltd. is shaped by the dynamics of the Indian and global chemical industry.
Bull Case: A robust growth trajectory could be supported by sustained demand from key end-user industries, successful execution of capacity expansions, diversification into high-margin specialty chemicals, effective cost management, and leveraging "China Plus One" opportunities for exports. Favorable government policies and stable raw material prices could further enhance profitability.
Bear Case: The company could face headwinds from intense pricing pressure due to oversupply or increased competition, inability to pass on escalating raw material costs, adverse currency movements, and strict environmental regulations requiring significant capital expenditure. A slowdown in the global economy or specific end-user sectors would also dampen demand and growth prospects.
Overall, the company's performance will depend on its ability to navigate the cyclical and competitive nature of the chemicals industry, manage input cost volatility, and strategically position its product portfolio.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 4 | 7 | 6 | 5 | 8 | 5 | 7 | 5 | 7 | 7 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 5 | 7 | 6 | 5 | 8 | 5 | 7 | 5 | 7 | 7 |
| Total Expenditure | 4 | 6 | 5 | 4 | 7 | 4 | 7 | 5 | 7 | 6 |
| Operating Profit | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Adjustments | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Adjusted Earnings Per Share | 1.1 | 3 | 2.2 | 2 | 3.3 | 1.7 | 2 | 1.2 | 1.8 | 2.4 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 6 | 8 | 8 | 17 | 21 | 25 | 26 |
| Other Income | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 1 | 0 | 0 | 0 | 0 | 6 | 8 | 8 | 17 | 22 | 26 | 26 |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 6 | 7 | 7 | 16 | 18 | 22 | 25 |
| Operating Profit | 1 | 0 | -0 | -0 | -0 | 1 | 1 | 1 | 1 | 3 | 4 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 0 | -0 | -0 | -0 | 1 | 1 | 1 | 1 | 3 | 4 | 3 |
| Provision for Tax | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Profit After Tax | 1 | 0 | -0 | -0 | -0 | 0 | 1 | 1 | 1 | 2 | 3 | 3 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | 0 | -0 | -0 | -0 | 0 | 1 | 1 | 1 | 2 | 3 | 3 |
| Adjusted Earnings Per Share | 2 | 0.3 | -0.5 | -0.6 | -0.6 | 1.5 | 1.9 | 1.9 | 2.3 | 7.2 | 9.1 | 7.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 19% | 46% | 33% | 0% |
| Operating Profit CAGR | 33% | 59% | 32% | 15% |
| PAT CAGR | 50% | 44% | 0% | 12% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -24% | 22% | 30% | 30% |
| ROE Average | 44% | 43% | 42% | 27% |
| ROCE Average | 60% | 59% | 51% | 32% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 2 | 3 | 5 | 7 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 3 |
| Total Liabilities | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 5 | 7 | 11 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 5 | 6 |
| Total Current Assets | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 2 | 4 |
| Total Assets | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 5 | 7 | 11 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Cash Flow from Operating Activities | 0 | -0 | -0 | -1 | -0 | 0 | 0 | 1 | 2 | 0 | 2 |
| Cash Flow from Investing Activities | 0 | 0 | 1 | 0 | 0 | -0 | -0 | -1 | -1 | -1 | -1 |
| Cash Flow from Financing Activities | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
| Net Cash Inflow / Outflow | 0 | 0 | 1 | -1 | -0 | -0 | -0 | -0 | 1 | -1 | 1 |
| Closing Cash & Cash Equivalent | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 2.04 | 0.29 | -0.54 | -0.65 | -0.57 | 1.48 | 1.91 | 1.89 | 2.31 | 7.15 | 9.09 |
| CEPS(Rs) | 2.2 | 0.29 | -0.54 | -0.64 | -0.53 | 1.55 | 1.99 | 1.98 | 2.39 | 7.31 | 9.26 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Book NAV/Share(Rs) | 3.05 | 3.33 | 2.79 | 2.15 | 1.58 | 3.06 | 4.98 | 6.87 | 9.18 | 16.33 | 24.92 |
| Core EBITDA Margin(%) | -150.78 | -45.71 | -142.62 | -476.04 | -161.32 | 9.18 | 8.62 | 9.41 | 4.95 | 13.04 | 13.25 |
| EBIT Margin(%) | 738.7 | 101.75 | -84.14 | -418.68 | -152.63 | 9.26 | 9.02 | 10.03 | 5.7 | 14.05 | 14.79 |
| Pre Tax Margin(%) | 720.15 | 89.44 | -115.24 | -432.65 | -158.6 | 9.18 | 8.81 | 9.83 | 5.61 | 14.02 | 14.58 |
| PAT Margin (%) | 644.75 | 64.82 | -115.24 | -373.09 | -162.5 | 7.15 | 7.51 | 7.14 | 4.15 | 10.1 | 10.87 |
| Cash Profit Margin (%) | 696.23 | 64.94 | -115.13 | -367.38 | -151.72 | 7.48 | 7.83 | 7.46 | 4.28 | 10.32 | 11.08 |
| ROA(%) | 43.75 | 5.9 | -11.19 | -17.01 | -20.59 | 28.16 | 21.71 | 18.03 | 17.17 | 36.01 | 30.88 |
| ROE(%) | 92.53 | 8.94 | -17.61 | -26.13 | -30.33 | 63.73 | 47.63 | 31.94 | 28.82 | 56.09 | 44.06 |
| ROCE(%) | 67.18 | 10.22 | -8.5 | -19.57 | -20.62 | 67.91 | 45.15 | 35.85 | 37.52 | 78.07 | 59.94 |
| Receivable days | 789.04 | 162.96 | 381.79 | 965.4 | 311.81 | 37.97 | 62.57 | 52.99 | 9.96 | 13.27 | 29.73 |
| Inventory Days | 32.36 | 21.12 | 14.8 | 0 | 23.33 | 0.38 | 0.22 | 0.13 | 0 | 0 | 0 |
| Payable days | 852.33 | 104.98 | 28.22 | 44.71 | 211.17 | 46.16 | 50 | 32 | 30.76 | 34.04 | 30.82 |
| PER(x) | 5.2 | 34.01 | 0 | 0 | 0 | 7.44 | 13.69 | 21.69 | 52.97 | 15.94 | 22.73 |
| Price/Book(x) | 3.48 | 2.91 | 4.46 | 5.82 | 9.32 | 3.59 | 5.27 | 5.97 | 13.34 | 6.98 | 8.29 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.48 |
| EV/Net Sales(x) | 23.13 | 19.16 | 22.94 | 68.86 | 42.24 | 0.43 | 0.98 | 1.58 | 2.14 | 1.6 | 2.44 |
| EV/Core EBITDA(x) | 2.93 | 18.8 | -27.3 | -16.67 | -29.78 | 4.5 | 10.53 | 15.26 | 36.77 | 11.23 | 16.28 |
| Net Sales Growth(%) | -77.3 | 39.19 | 6.37 | -63.04 | 101.16 | 5843.38 | 23.16 | 4 | 110.49 | 27.07 | 17.98 |
| EBIT Growth(%) | 0 | -80.83 | -187.96 | -83.92 | 26.66 | 460.55 | 20 | 15.61 | 19.57 | 213.45 | 24.17 |
| PAT Growth(%) | 2458.02 | -86.01 | -289.12 | -19.67 | 12.39 | 361.62 | 29.37 | -1.21 | 22.26 | 209.51 | 27.03 |
| EPS Growth(%) | 2458.06 | -86.01 | -289.11 | -19.67 | 12.38 | 361.6 | 29.37 | -1.21 | 22.26 | 209.51 | 27.03 |
| Debt/Equity(x) | 0.4 | 0.35 | 0.71 | 0.22 | 0.6 | 0.02 | 0.42 | 0.13 | 0 | 0 | 0 |
| Current Ratio(x) | 2.47 | 2.24 | 2.1 | 3.19 | 1.51 | 1.52 | 1.85 | 0.96 | 0.6 | 1.04 | 1.44 |
| Quick Ratio(x) | 2.44 | 2.24 | 2.09 | 3.19 | 1.5 | 1.51 | 1.85 | 0.96 | 0.6 | 1.04 | 1.44 |
| Interest Cover(x) | 39.82 | 8.27 | -2.71 | -29.97 | -25.59 | 116.69 | 42.92 | 50.55 | 64.66 | 423.53 | 70.9 |
| Total Debt/Mcap(x) | 0.12 | 0.12 | 0.16 | 0.04 | 0.06 | 0 | 0.08 | 0.02 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 32.09 | 32.11 | 32.05 | 32.04 | 32.11 | 32.22 | 29.43 | 29.69 | 29.94 | 30.04 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 |
| Public | 67.78 | 67.76 | 67.82 | 67.83 | 67.76 | 67.65 | 70.44 | 70.18 | 69.93 | 69.83 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.09 | 0.09 | 0.09 | 0.09 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.21 | 0.21 | 0.21 | 0.21 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +19% | +46% | +33% | — |
| Operating Profit CAGR | +33% | +59% | +32% | +15% |
| PAT CAGR | +50% | +44% | — | +12% |
| Share Price CAGR | -24% | +22% | +30% | +30% |
| ROE Average | +44% | +43% | +42% | +27% |
| ROCE Average | +60% | +59% | +51% | +32% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 32.09 | 32.11 | 32.05 | 32.04 | 32.11 | 32.22 | 29.43 | 29.69 | 29.94 | 30.04 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 |
| Public | 67.91 | 67.89 | 67.95 | 67.96 | 67.89 | 67.78 | 70.57 | 70.31 | 70.06 | 69.96 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.09 | 0.09 | 0.09 | 0.09 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.21 | 0.21 | 0.21 | 0.21 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.